Outcomes of Large B-Cell Lymphoma Patients By Post CAR-T Salvage Regimen at a Single Institution

被引：2
|
作者：
Sigmund, Audrey M. [1 ]
Denlinger, Nathan [1 ]
Bajwa, Amneet [2 ]
Elder, Patrick [1 ]
Bond, David A. [1 ]
Brammer, Jonathan E. [1 ]
Saad, Ayman [1 ]
Penza, Sam [1 ]
de Lima, Marcos J. G. [1 ]
Jaglowski, Samantha [1 ]
Kittai, Adam S. [1 ]
机构：
[1] Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH USA
[2] Ohio State Univ, Div Hosp Med, Dept Internal Med, Columbus, OH USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-148751
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3851
引用
收藏
页码：3851 / +
页数：5
相关论文
共 50 条
  • [21] Analysis of CAR-T and Immune Cells within the Tumor Micro-Environment of Diffuse Large B-Cell Lymphoma Post CAR-T Treatment By Multiplex Immunofluorescence
    Chen, Pei-Hsuan
    Lipschitz, Mikel
    Wright, Kyle
    Armand, Philippe
    Jacobson, Caron A.
    Roberts, Zachary J.
    Rossi, John M.
    Bot, Adrian
    Go, William Y.
    Rodig, Scott J.
    BLOOD, 2018, 132
  • [22] CAR-T for large B-cell lymphomas: the clock is ticking
    Chong, Elise A.
    BLOOD ADVANCES, 2024, 8 (11) : 2980 - 2981
  • [23] Single-Center Experience of Axicabtagene Ciloleucel CAR-T Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma
    Melody, Megan
    Rahman, Zaid Abdel
    Ernesto, Ayala
    Gannon, Nicole
    Roy, Vivek
    Sher, Taimur
    Ailawadhi, Sikander
    Foran, James
    Dabaja, Mohamed Kharfan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S267 - S268
  • [24] NICE approves routine NHS use of CAR-T for diffuse large B-cell lymphoma
    Wilkinson, Emma
    LANCET ONCOLOGY, 2023, 24 (03): : 208 - 208
  • [25] Assessing and Management of Neurotoxicity After CAR-T Therapy in Diffuse Large B-Cell Lymphoma
    Castaneda-Puglianini, Omar
    Chavez, Julio C.
    JOURNAL OF BLOOD MEDICINE, 2021, 12 : 775 - 783
  • [26] Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma: Is It Time to Consider CAR-T for All
    Zelenetz, Andrew D.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (12): : 1764 - 1766
  • [27] Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment
    Iacoboni, Gloria
    Navarro, Victor
    Sesques, Pierre
    Rejeski, Kai
    Bastos-Oreiro, Mariana
    Serpenti, Fabio
    Martin Lopez, Ana Africa
    Iraola-Truchuelo, Josu
    Delgado, Javier
    Perez, Ariadna
    Guerreiro, Manuel
    Caballero, Ana Carolina
    Martinez-Cibrian, Nuria
    Luzardo Henriquez, Hugo
    Sanchez Pina, Jose Maria
    Sancho, Juan-Manuel
    Ghesquieres, Herve
    Mussetti, Alberto
    Lopez Corral, Lucia
    Hernani, Rafael
    Reguera, Juan Luis
    Sureda, Anna
    Bosch, Francesc
    Martin Garcia-Sancho, Alejandro
    Kwon, Mi
    Subklewe, Marion
    Kuhnl, Andrea
    Bachy, Emmanuel
    Barba, Pere
    Villacampa, Guillermo
    Abrisqueta, Pau
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)
  • [28] Cellular Therapy Updates in B-Cell Lymphoma: The State of the CAR-T
    Crees, Zachary D.
    Ghobadi, Armin
    CANCERS, 2021, 13 (20)
  • [29] Diffuse large B-cell lymphoma: A single-institution experience of patient outcomes
    Chan, Ryan James
    Gupta, Rasna
    Kanjeekal, Sindu Mary
    Jarrar, Mohammed
    Kay, Amin
    Mathews, John
    Woldie, Indryas Lemma
    Hamm, Caroline M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [30] CAR T in patients with large B-cell lymphoma not fit for autologous transplant
    Kuhnl, A.
    Kirkwood, A. A.
    Roddie, C.
    Menne, T.
    Tholouli, E.
    Bloor, A.
    Besley, C.
    Chaganti, S.
    Osborne, W.
    Norman, J.
    Gibb, A.
    Sharplin, K.
    Cuadrado, M.
    Correia de Farias, M.
    Cheok, K.
    Neill, L.
    Latif, A. L.
    Gonzalez Arias, C.
    Uttenthal, B.
    Jones, C.
    Johnson, R.
    McMillan, A.
    Sanderson, R.
    Townsend, W.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (01) : 65 - 73
12345